The myHER2 app is an interactive and personalised support tool designed for women or men with HER2-positive breast cancer who have been prescribed Herceptin (trastuzumab) or Perjeta (pertuzumab) + Herceptin or Kadcyla (trastuzumab emtansine).
The Home Screen displays the key modules of the app.
The app includes features such as:
• Treatment Plan - to assist in managing infusion appointments
• Symptom Tracker - to log symptoms and track well-being
• Support Resources - information about HER2-positive breast cancer, treatment and direct access to support networks
• Personal Profile - to store the healthcare and emergency contact details.